Is VIRX stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 21st of November 2014, Viracta Therapeutics Inc had a stock price of $446.32. If you invested back then, your return now would be a loss of $-446.17 per share or -99.97%
No, the average daily trading liquidity for Viracta Therapeutics Inc is $265 107 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Viracta Therapeutics Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Viracta Therapeutics Inc to be medium [0.7 out of 1]